NCT06967324 GRACE - Graduated Response for Advanced COPD With Enhanced Support
| NCT ID | NCT06967324 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Copenhagen University Hospital, Hvidovre |
| Condition | COPD (Chronic Obstructive Pulmonary Disease) |
| Study Type | INTERVENTIONAL |
| Enrollment | 100 participants |
| Start Date | 2025-08-07 |
| Primary Completion | 2026-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 100 participants in total. It began in 2025-08-07 with a primary completion date of 2026-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of this study is to explore the feasibility and potential for a positive impact of a graduated response for advanced COPD with Enhanced Support. The study is a randomized controlled trial of: * systematic needs assessment * advance care planning * crossectoral virtual conferences. Researchers will compare quality of life and healthcare use of the intervention group with a control group that will be assessed for intervention need at the last follow-up.
Eligibility Criteria
Inclusion Criteria: * COPD * Exacerbation within the last year * Living in Høje Taastrup or Copenhagen * Cognitively relevant * ICECAP-SCM at least two scores of: 1. 1, 2 2. 1, 2 3. 1, 2 4. 1, 2 5. 1, 2, 3 6. 1, 2 7. 1, 2 Exclusion Criteria: * Dementia * Psychosis * Substance abuse * Hearing or speech impairment * Cancer * Receiving specialized palliative care or other similar interventions * Immediately dying
Contact & Investigator
Kirstine Benthien, Ph.d.
PRINCIPAL INVESTIGATOR
Copenhagen University Hospital, Hvidovre
Frequently Asked Questions
Who can join the NCT06967324 clinical trial?
This trial is open to participants of all sexes, aged 65 Years or older, studying COPD (Chronic Obstructive Pulmonary Disease). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06967324 currently recruiting?
Yes, NCT06967324 is actively recruiting participants. Contact the research team at isabella.drachmann.camilleri@regionh.dk for enrollment information.
Where is the NCT06967324 trial being conducted?
This trial is being conducted at Hvidovre, Denmark.
Who is sponsoring the NCT06967324 clinical trial?
NCT06967324 is sponsored by Copenhagen University Hospital, Hvidovre. The principal investigator is Kirstine Benthien, Ph.d. at Copenhagen University Hospital, Hvidovre. The trial plans to enroll 100 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.